·Î±×ÀÎ Àüü´º½º¿ÀÇǴϾðEnglishÆÊ ¾ÆÄ«µ¥¹ÌÆʽºÅ¸Å¬·´TVÆʵµ¶ó¸®Äí¸£Æ®DPºÎµ¿»êÀλ絿Á¤Event & Çмú¼¼¹Ì³ªµ¶ÀÚÁ¦º¸
°Ë»ö ä¿ëÁ¤º¸ ÀÓÁ¾À± Çѹ̻çÀ̾𽺠»çÀå, 120¾ï ÁÖ½Ä Àå³»¸Åµµ ±â»çÀÔ·Â : 24.12.06 16:44:17 0 °¡ ÇÃÄ£Ãß°¡ º¸À¯ ÁÖ½Ä 4.6% óºÐ...ÁöºÐÀ² 12.46%¡æ11.89% [µ¥Àϸ®ÆÊ=õ½ÂÇö ±âÀÚ] Çѹ̻çÀ̾𽺴 ÀÓÁ¾À± »çÀåÀÌ ÁÖ½Ä 38¸¸9838ÁÖ¸¦ Àå³»¸ÅµµÇß´Ù°í 6ÀÏ °ø½ÃÇß´Ù. º¸À¯ ÁÖ½Ä 852¸¸2381ÁÖ Áß 4.6%¸¦ Àå³»¿¡¼ ÆȾҴÙ. óºÐ±Ý¾×Àº ÃÑ 120¾ï¿øÀÌ´Ù. ÀÓ »çÀåÀÇ ÁÖ½Ä Ã³ºÐÀ¸·Î Çѹ̻çÀ̾𽺠ÁöºÐÀ²Àº 12.46%¿¡¼ 11.89%·Î ³·¾ÆÁ³´Ù. X AD ÇÇÁö¿À¸Ó¿Í ÇÔ²²! À̺¥Æ®Âü¿© ¡æ õ½ÂÇö ±âÀÚ(1000@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç ´õÇö´ë ¼¿ï ÇÍŸ¹Î ¾à±¹ ÆÄÆ® ¾à»ç ä¿ë ¹Ù·Î°¡±â Á¶¾ÆÁ¦¾à Ç°Áú°ü¸®¾à»ç °æ·Â ä¿ë ¹Ù·Î°¡±â Medical Science Liaison (Oncology) / Head of Market Access & External Affairs / MR(¿µ¾÷ºÎ) ä¿ë ¹Ù·Î°¡±â °³¹ß±âȹÆÀ BD °æ·Â(7³â ÀÌ»ó)ä¿ë ¹Ù·Î°¡±â Çѱ¹¿¡ÀÚÀÌ Medical Scientific Affair ä¿ë(À°¾ÆÈÞÁ÷´ëü_±â°£Á¦) ¹Ù·Î°¡±â Sr. Regulatory Affairs Specialist (18 months contract) ¹Ù·Î°¡±â ÇØÅÂhtb ÀÍ»ê°øÀå °ü¸®¾à»ç ä¿ë ¹Ù·Î°¡±â ¢ß¼¿Æ®¸®¿ÂÁ¦¾à ½ÅÀÔ/°æ·Â ¼ö½Ãä¿ë ¹Ù·Î°¡±â Junior Marketing Manager ä¿ë ¹Ù·Î°¡±â Medical Representative (Ŭ¸®´Ð ¿µ¾÷ - °è¾àÁ÷) ¹Ù·Î°¡±â Á¦¾à¾à»çä¿ë ¹Ù·Î°¡±â ¼¿Æ®¸®¿Â 2025³â 1Â÷ ½ÅÀÔ/°æ·Â ¼ö½Ãä¿ë ¹Ù·Î°¡±â Medical Representative (Á¾º´ ¿µ¾÷ - °è¾àÁ÷) ¹Ù·Î°¡±â (Sr.) Local Research Specialist ¹Ù·Î°¡±â QC, QA, Medical Affairs, MR(º´¿ø¿µ¾÷) ä¿ë ¹Ù·Î°¡±â Senior Regulatory Science Specialist(1Yr) ¹Ù·Î°¡±â PMS Lead (Fixed-term) ¹Ù·Î°¡±â ¸¶ÄÉÆà ¾à»ç, Àü¹®¿¬±¸¿ä¿ø ¸ðÁý ¹Ù·Î°¡±â Ç°Áú±×·ìÀå(ÀÌ»ç±Þ), °ü¸®¾à»ç ¸ðÁý ¹Ù·Î°¡±â Æĸ¶¿¡¼¾½Ã¾ÆÄÚ¸®¾Æ MSL ½Å±Ô ä¿ë ¹Ù·Î°¡±â ÀÓ»óÆÀ PM °æ·Â(2³â ÀÌ»ó) ä¿ë ¹Ù·Î°¡±â ÀÓ»óÆÀ¿ø(Á¤±ÔÁ÷), RA/QAÆÀ¿ø,PVÆÀ¿ø(°è¾àÁ÷) ä¿ë ¹Ù·Î°¡±â [À¯¸í¿Ü±¹°èÁ¦¾à»ç] ÀÓ»ó°ü·Ã(½ÅÀÔ¾à»ç Áö¿ø°¡´É) & MSLµî ´Ù¼ö ¹Ù·Î°¡±â (ÀüºÏ(ÀüÁÖ °ÅÁÖ)) ¿µ¾÷ºÎ ½ÅÀÔ/°æ·ÂÁ÷(ÁÖÀÓ~´ë¸®±Þ) ¸ðÁý ¹Ù·Î°¡±â Çѱ¹¿¡ÀÚÀÌ Sr. MSL Associate ä¿ë(Á¤±ÔÁ÷) ¹Ù·Î°¡±â 0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æħ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2025,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : ÀÓÁ¾À± Çѹ̻çÀ̾𽺠»çÀå, 120¾ï ÁÖ½Ä Àå³»¸Åµµ URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ Ä«Ä«¿À½ºÅ丮 Ä«Ä«¿ÀÅå ¹êµå ³×À̹ö
ä¿ëÁ¤º¸ ÀÓÁ¾À± Çѹ̻çÀ̾𽺠»çÀå, 120¾ï ÁÖ½Ä Àå³»¸Åµµ ±â»çÀÔ·Â : 24.12.06 16:44:17 0 °¡ ÇÃÄ£Ãß°¡ º¸À¯ ÁÖ½Ä 4.6% óºÐ...ÁöºÐÀ² 12.46%¡æ11.89% [µ¥Àϸ®ÆÊ=õ½ÂÇö ±âÀÚ] Çѹ̻çÀ̾𽺴 ÀÓÁ¾À± »çÀåÀÌ ÁÖ½Ä 38¸¸9838ÁÖ¸¦ Àå³»¸ÅµµÇß´Ù°í 6ÀÏ °ø½ÃÇß´Ù. º¸À¯ ÁÖ½Ä 852¸¸2381ÁÖ Áß 4.6%¸¦ Àå³»¿¡¼ ÆȾҴÙ. óºÐ±Ý¾×Àº ÃÑ 120¾ï¿øÀÌ´Ù. ÀÓ »çÀåÀÇ ÁÖ½Ä Ã³ºÐÀ¸·Î Çѹ̻çÀ̾𽺠ÁöºÐÀ²Àº 12.46%¿¡¼ 11.89%·Î ³·¾ÆÁ³´Ù. X AD ÇÇÁö¿À¸Ó¿Í ÇÔ²²! À̺¥Æ®Âü¿© ¡æ õ½ÂÇö ±âÀÚ(1000@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç ´õÇö´ë ¼¿ï ÇÍŸ¹Î ¾à±¹ ÆÄÆ® ¾à»ç ä¿ë ¹Ù·Î°¡±â Á¶¾ÆÁ¦¾à Ç°Áú°ü¸®¾à»ç °æ·Â ä¿ë ¹Ù·Î°¡±â Medical Science Liaison (Oncology) / Head of Market Access & External Affairs / MR(¿µ¾÷ºÎ) ä¿ë ¹Ù·Î°¡±â °³¹ß±âȹÆÀ BD °æ·Â(7³â ÀÌ»ó)ä¿ë ¹Ù·Î°¡±â Çѱ¹¿¡ÀÚÀÌ Medical Scientific Affair ä¿ë(À°¾ÆÈÞÁ÷´ëü_±â°£Á¦) ¹Ù·Î°¡±â Sr. Regulatory Affairs Specialist (18 months contract) ¹Ù·Î°¡±â ÇØÅÂhtb ÀÍ»ê°øÀå °ü¸®¾à»ç ä¿ë ¹Ù·Î°¡±â ¢ß¼¿Æ®¸®¿ÂÁ¦¾à ½ÅÀÔ/°æ·Â ¼ö½Ãä¿ë ¹Ù·Î°¡±â Junior Marketing Manager ä¿ë ¹Ù·Î°¡±â Medical Representative (Ŭ¸®´Ð ¿µ¾÷ - °è¾àÁ÷) ¹Ù·Î°¡±â Á¦¾à¾à»çä¿ë ¹Ù·Î°¡±â ¼¿Æ®¸®¿Â 2025³â 1Â÷ ½ÅÀÔ/°æ·Â ¼ö½Ãä¿ë ¹Ù·Î°¡±â Medical Representative (Á¾º´ ¿µ¾÷ - °è¾àÁ÷) ¹Ù·Î°¡±â (Sr.) Local Research Specialist ¹Ù·Î°¡±â QC, QA, Medical Affairs, MR(º´¿ø¿µ¾÷) ä¿ë ¹Ù·Î°¡±â Senior Regulatory Science Specialist(1Yr) ¹Ù·Î°¡±â PMS Lead (Fixed-term) ¹Ù·Î°¡±â ¸¶ÄÉÆà ¾à»ç, Àü¹®¿¬±¸¿ä¿ø ¸ðÁý ¹Ù·Î°¡±â Ç°Áú±×·ìÀå(ÀÌ»ç±Þ), °ü¸®¾à»ç ¸ðÁý ¹Ù·Î°¡±â Æĸ¶¿¡¼¾½Ã¾ÆÄÚ¸®¾Æ MSL ½Å±Ô ä¿ë ¹Ù·Î°¡±â ÀÓ»óÆÀ PM °æ·Â(2³â ÀÌ»ó) ä¿ë ¹Ù·Î°¡±â ÀÓ»óÆÀ¿ø(Á¤±ÔÁ÷), RA/QAÆÀ¿ø,PVÆÀ¿ø(°è¾àÁ÷) ä¿ë ¹Ù·Î°¡±â [À¯¸í¿Ü±¹°èÁ¦¾à»ç] ÀÓ»ó°ü·Ã(½ÅÀÔ¾à»ç Áö¿ø°¡´É) & MSLµî ´Ù¼ö ¹Ù·Î°¡±â (ÀüºÏ(ÀüÁÖ °ÅÁÖ)) ¿µ¾÷ºÎ ½ÅÀÔ/°æ·ÂÁ÷(ÁÖÀÓ~´ë¸®±Þ) ¸ðÁý ¹Ù·Î°¡±â Çѱ¹¿¡ÀÚÀÌ Sr. MSL Associate ä¿ë(Á¤±ÔÁ÷) ¹Ù·Î°¡±â 0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æħ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2025,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : ÀÓÁ¾À± Çѹ̻çÀ̾𽺠»çÀå, 120¾ï ÁÖ½Ä Àå³»¸Åµµ URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ Ä«Ä«¿À½ºÅ丮 Ä«Ä«¿ÀÅå ¹êµå ³×À̹ö
ä¿ëÁ¤º¸ ÀÓÁ¾À± Çѹ̻çÀ̾𽺠»çÀå, 120¾ï ÁÖ½Ä Àå³»¸Åµµ ±â»çÀÔ·Â : 24.12.06 16:44:17 0 °¡ ÇÃÄ£Ãß°¡ º¸À¯ ÁÖ½Ä 4.6% óºÐ...ÁöºÐÀ² 12.46%¡æ11.89% [µ¥Àϸ®ÆÊ=õ½ÂÇö ±âÀÚ] Çѹ̻çÀ̾𽺴 ÀÓÁ¾À± »çÀåÀÌ ÁÖ½Ä 38¸¸9838ÁÖ¸¦ Àå³»¸ÅµµÇß´Ù°í 6ÀÏ °ø½ÃÇß´Ù. º¸À¯ ÁÖ½Ä 852¸¸2381ÁÖ Áß 4.6%¸¦ Àå³»¿¡¼ ÆȾҴÙ. óºÐ±Ý¾×Àº ÃÑ 120¾ï¿øÀÌ´Ù. ÀÓ »çÀåÀÇ ÁÖ½Ä Ã³ºÐÀ¸·Î Çѹ̻çÀ̾𽺠ÁöºÐÀ²Àº 12.46%¿¡¼ 11.89%·Î ³·¾ÆÁ³´Ù. X AD ÇÇÁö¿À¸Ó¿Í ÇÔ²²! À̺¥Æ®Âü¿© ¡æ õ½ÂÇö ±âÀÚ(1000@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç
0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æħ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2025,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : ÀÓÁ¾À± Çѹ̻çÀ̾𽺠»çÀå, 120¾ï ÁÖ½Ä Àå³»¸Åµµ URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ Ä«Ä«¿À½ºÅ丮 Ä«Ä«¿ÀÅå ¹êµå ³×À̹ö